By taking a digital maturity-first approach to Pharma 4.0, manufacturers can optimally position themselves for success.
Nicola Gardner
Advertisement
Nicola Gardner is senior product marketing manager at Thermo Fisher Scientific.
Articles by Nicola Gardner
Advertisement
Latest Updated Articles
Smoothing the Path to Pharma 4.0: Challenges and SolutionsNovember 15th 2022
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
2
FDA Rare Disease Framework Initiative: What It Means for Drug and Biologic Development
3
BioNTech's BNT113 Misses PFS Goal in Head and Neck Cancer Trial
4
Gilead Taps Vir Biotechnology's PRO-XTEN Tech for Solid Tumors
5